SWOG clinical trial number
E8897

Correlation of Histopathology, Immunohistochemistry and Quantitative Radiology with Outcome in Early Stage Nonseminomatous Germ Cell Tumor

Closed
Phase
Abbreviated Title
Testicular
Activated
10/01/2002
Closed
12/28/2004
Participants
NCORP, Members, UCOP, Medical Oncologists, Radiation Oncologists, Surgeons, Pathologists

Research committees

Genitourinary Cancer

Treatment

Surgery

Eligibility Criteria Expand/Collapse

Pts must have clinical Stage A nonseminomatous germ cell tumor of the testis. AFP and HCG must be normal or falling after orchiectomy at a rate consistent w/known half lives. Pt must have no evidence of mets on PE, chest x-ray, or abd/pelvic CT w/in 4 wks from reg. Pts must have had radical inguinal orchiectomy or simultaneous orchiectomy and RPLND w/in 12 wks prior to reg. Pt must have no hx of malignancy including prior testis primary. Pt must have pure seminoma (unless assoc w/elev AFP at dx). Pts must not be managed w/primary chemo. Pts must be >/= 15 years.

Other Clinical Trials

SWOG Clinical Trial Number
S2312
SWOG Clinical Trial Number
S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"

Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
7%
Open
Phase
SWOG Clinical Trial Number
S2200